Tonix Pharma (TNXP) Misses Q1 EPS by 35c
Tweet
Share
E-mailGet Alerts TNXP Hot Sheet
Join SI Premium – FREE
Tonix Pharma (NASDAQ: TNXP) reported Q1 EPS of ($2.93), $0.35 worse than the analyst estimate of ($2.58). Revenue for the quarter came in at $6.88 million versus the consensus estimate of $9.2 million.
For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Vicor Corporation (VICR) PT Raised to $400 at Needham
- DraftKings (DKNG) Reiterated at Buy by Benchmark as Environment Stays Bettor-Friendly
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
